Právní předpis byl sestaven k datu 10.12.2024.
Zobrazené znění právního předpisu je účinné od 10.12.2024.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2025
375/2024 Sb.
375
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 5. xxxxxxxx 2024
x xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx rok 2025
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx doporučení Xxxxxxx imunizační xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2025:
1. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx anatoxinum1 xx méně xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum filamentosum (XXX)1 25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum (XXX)
xx xxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 xxxxxxxxxx
xxxx. cum xxxxxx. xxxxxxxx jako xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 xxxxxxxxxxx xx hydroxid xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Al3+
2 vyrobeno xxxxxxxxxxxxx DNA technologií xx kultuře xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae)
3 xxxxxxxxxxx xx fosforečnan xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx forma), xxxxxx hepatitidě B, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx dávka1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 mezinárodních jednotek (XX)2,4 (30 Lf)
Tetani xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)3,4 (10 Xx)
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis xxxxxxxxxx 25 mikrogramů
Pertussis xxxxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)5
xxxxx 1 (Xxxxxxx) 29 X xxxxxxxx xxxxxxxx6
xxxxx 2 (MEF-1) 7 X xxxxxxxx xxxxxxxx6
xxxxx 3 (Xxxxxxx) 26 X jednotek xxxxxxxx6
Xxxxxxxxx xxxxxxxxxxx X xxxxxxxxx7 10 xxxxxxxxxx
Xxxxxxxxxx xxxxxxxxxx xxxx X xxxxxxxxxxxxxxx (Xxxxxxxxxxxxxxxxxxx phosphas) 12 xxxxxxxxxx xxxxxxxxxx xxx xxxxxx proteino 22-36 xxxxxxxxxx
1 Adsorbováno xx xxxxxxxxxxx hydroxid hlinitý (0,6 xx Xx3+)
2 Xxxx xxxxxx mez xxxxxxxxxxxxx (p = 0,95) a xx xxxx než 30 XX xxxx xxxxxxx xxxxxxx
3 Xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
4 Xxxx xxxxxxxxxxxx xxxxxxxx stanovená xxxxxxxxxx xxxxxxxxxxx
5 Xxxxxxxxxxx xx Xxxx xxxxxxx
6 Xxxx množství xxxxxxxx xxxx úplně xxxxxx xxxx ta, xxxxx xxxx xxxxx xxxxxxxxx xxxx 40-8-32 X xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx metodou
7 xxxxxxxx rekombinantní DNA xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx záškrtu, xxxxxx, dávivému kašli (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (rDNA), dětské xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx vakcína xxxxx Xxxxxxxxxxx xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne méně xxx 20 IU6
Tetani xxxxxxxxxx1 xx méně xxx 40 IU6
Antigena Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 2,3 10 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (MEF-1) 8 D xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx influenzae xxxxx b
(Polyribosylribitoli xxxxxxxx) 3 mikrogramy xxxxxxxxxx xxx proteinům meningococci xxxxx x2 50 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hlinitý (0,17 xx Al3+)
2 xxxxxxxxxxx xx hydratovaný hydroxid xxxxxxx sulfát (0,15 xx Xx3+)
3 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x kvasinkových buňkách Xxxxxxxxxxxxx xxxxxxxxxx
4 pomnoženo xx Xxxx xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx metodou
6 xxxx xxxxxxxxxxxx xxxxxxxx stanovená xxxxxxxxxxxx xxxxxxxxxxx
1x) očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX)
Xxxxx xxxxx (0,5 ml) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum* (XXX) 25 mikrogramů
Pertactinum* (69xX) 8 xxxxxxxxxx
* xxxxxxxxxxx na xxxxxxxx xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx kašli (xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx anatoxinum - 2,5 mikrogramů
Haemagglutinum xxxxxxxxxxxx - 5 mikrogramů
Pertactinum - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx záškrtu, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Xxxx)
Xxxxx dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 ne xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (X1(XX)3) 0,3 xxxxxxxxx Xx3+ x fosforečnan xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Haemophilus influenzae xxx x:
Xx rekonstituci 1 xxxxx (0,5 xx) obsahuje:
Haemophilus influenzae xxxxx b xxxx xxxxxxxxxxx 10 xxxxxxxxxx
xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx nosičem xxxxxxxxx 25 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - min. 40 xxxxxxxxxxxxx jednotek
1e) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx B - 10 mikrogramů
1f) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx B x xxxxxxx formuli
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x zarděnkám:
dávka xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx kuřecích xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx buňkách (MRC-5)
3 50% infekční xxxxx xxxxxxx xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx a zarděnkám
Po xxxxxxxxxx xxxxxxxx jedna xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Wistar XX 27/3) ne xxxx xxx 1x103 CCID50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx buňkách xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum typus 1 (Xxxxxxx) ... 29 xxxxxxxxxxx D xxxxxxxx**
Xxxxx poliomyelitis inactivatum xxxxx 2 (MEF-1) ... 7 xxxxxxxxxxx X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ) ... 26 antigenních D xxxxxxxx**
* Kultivováno xx XXXX xxxxxxx
** Tato xxxxxxxx xxxxxxxx jsou xxxxx xxxxxx xxxx xx, xxxxx xxxx xxxxx vyjádřená jako 40-8-32 D xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
1xx) konjugovaná xxxxxxxx látka proti xxxxxxxxxxxxx xxxxxxxx
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 1 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 3 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 4 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 5 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx sérotypu 6A 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 6B 1,2 4,4 µg
polysacharid xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7F 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 8 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 9 X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 10X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 11X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 12X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 14 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 15X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae sérotypu 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 22X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 23X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33X 1,2 2,2 µx
1 Xxxxxxxxxx s xxxxxx xxxxxxxxx CRM197 (xxxxxxxxx 51 µx xx xxxxx)
2 Xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx xx xxxxx)
XXXX
1xxx) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 31,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 41,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 51,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx serotypi 6X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6B1,2 xxxxxxxxxxxxxxx 4,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7F1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 9V1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 141,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18C1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 22F1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 23X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 33X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
1 Xxxxxxxxxx x proteinovým xxxxxxx XXX197, CRM197 xx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxxx (xxxxxxxxxxxxx x Xxxxxxxxxxxxxxx xxxxxxxxxxx X7) rekombinantně exprimováného x Xxxxxxxxxxx fluorescens
2 Xxxxxxxxxx xx xxxxxxxx xxxxxxxxxxx hlinitý
A
1chab) póly xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9V, 10X, 11A, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X
XXXX
1xxx) xxxxxxxx xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 7X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 18C1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23F1 2,2 µx
1 Xxxxxxxxxx x xxxxxx xxxxxxxxx CRM197 x adsorbován xx xxxxxxxxxxx hlinitý (0,125 xx xxxxxxx)
X
1xxxx) xxxx xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7F, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18X, 19F, 19X, 20, 22F, 23F, 33X
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx než 2 mezinárodní jednotky (XX) (2,5 Lf)
Tetani xxxxxxxxxx1-&xxxx; xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx pertussis xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 mikrogramů
Virus xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 32 X xxxxxxxx xxxxxxxx
1 adsorbováno na xxxxxxxxxxx hydroxid hlinitý (Xx(XX)3) 0,3 miligramu Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX buňkách
NEBO
1ia) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx):
Xxxxx dávka (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx xxxxxxxxx 2 XX1 (2 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 XX1 (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 mikrogramů
Pertactinum 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)2
xxxxx 1 (Xxxxxxx) 29 X xxxxxxxx antigenu3
typus 2 (MEF1) 7 X xxxxxxxx xxxxxxxx3
xxxxx 3 (Saukett) 26 X jednotek xxxxxxxx3
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 xx Al3+)
1 Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx měřené xxxxx xxxxx popsaného x Evropském lékopisu
2 Xxxxxxxxxxx xx Vero xxxxxxx
3 Xxxx xxxxxxxx xxxxxxxx jsou úplně xxxxxx xxxx ta, xxxxx byla dříve xxxxxxxxx xxxx 40-8-32 X jednotek xxxxxxxx xxx virus typu 1, 2 a 3, při měření xxxxx vhodnou imunochemickou xxxxxxx
* Jako xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx popsaného x Xxxxxxxxx lékopisu
** Xxxxxxxxxxx xx Vero xxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx dialyzačního xxxxxxxx:
Xxxxx xxxxx (0,5 ml) xxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx B1,2,3 - 20 mikrogramů
1 xxxxxxxxxx xx AS04C xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx A (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae) xxxxxxxxxxxxx DNA technologií.
2. Xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
2x) očkovací látka xxxxx vzteklině
2c) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Wistar XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou kulturu503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx tkáňové xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx B) xx méně xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx RA 27/3) xx méně než 1x103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx WI-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxx očkování
3a) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx A ve xxxxxxx xxx dospělé:
Virus xxxxxxxxx X inactivatum
3b) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě A xx xxxxxxx pro xxxx:
Xxxxx hepatitis X xxxxxxxxxxx
3x) očkovací látka xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx vakcíny (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Schwarz) min. 103,0 infekční xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 pomnoženo na xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% infekční xxxxx tkáňové kultury
NEBO
3ca) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Lynn™, xxxxxxx X) xx xxxx než 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) ne xxxx xxx 1x1103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx kultury
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 vyrobeno xx lidských xxxxxxxxxxx xxxxxxxx XX-38 fibroblastech.
Ministr:
prof. XXXx. Xxxxx, XXx., XXX, XXXX, v. x.
Informace
Právní xxxxxxx č. 375/2024 Xx. xxxxx xxxxxxxxx xxxx 10.12.2024.
Ke xxx xxxxxxxx xxxxx xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x odkazech není xxxxxxxxxxxxx, pokud xx xxxx netýká xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.